Graves’ disease after COVID-19 vaccination
Marvin Wei Jie Chua
Abstract
Dear Editor, Case 1 was a 41-year-old man with a history of primary hyperthyroidism. At the time of diagnosis, thyroglobulin antibodies were elevated although no thyrotropin receptor antibodies (TRAB) were available. The patient was treated with carbimazole for 20 months. At the time of cessation of carbimazole in May 2020, thyroid function and TRAB levels
Topics & Concepts
MedicineCoronavirus disease 2019 (COVID-19)Graves' disease2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)VaccinationVirologyDiseaseBetacoronavirusMEDLINECoronavirus InfectionsOutbreakInternal medicineInfectious disease (medical specialty)Political scienceLawSARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesInfectious Encephalopathies and Encephalitis